Results 111 to 120 of about 2,012,581 (282)

Effort-Reward Imbalance at Work and Prescription Drug Misuse-Prospective Evidence from Germany. [PDF]

Int J Environ Res Public Health, 2022
Sattler S, von dem Knesebeck O.
europepmc   +1 more source

Drugs and crime in Ireland: overview 3

, 2006
The Overview series This publication series from the Drug Misuse Research Division of the Health Research Board provides a comprehensive review of specific drug-related issues in Ireland.
Connolly, Johnny
core  

Racial and Ethnic Disparities and Prevalence in Prescription Drug Misuse, Illicit Drug Use, and Combination of Both Behaviors in the United States. [PDF]

Int J Ment Health Addict, 2023
Lee YH, Woods C, Shelley M, Arndt S, Liu CT, Chang YC.   +5 more
europepmc   +1 more source

Comparison of Healthcare Utilization Before Diagnosis Between Non‐Advanced and Advanced Lung Cancer Patients: A Study Among 72,851 Cases in Germany

International Journal of Cancer, EarlyView.
ABSTRACT There is no study from Germany on the association between stage of lung cancer (LC) and patient characteristics. We aimed to compare advanced versus non‐advanced LC cases regarding indicators of healthcare utilization. Using claims data covering 20% of the German population, we included LC patients diagnosed between 2013 and 2019.
Josephine Küsel‐Kanbach, Oliver Riedel, Ulrike Haug   +2 more
wiley   +1 more source

Ohio Prescription Drug Abuse Task Force: Final Report Task Force Recommendations [PDF]

, 2010
On April 2, 2010, Governor Ted Strickland signed Executive Order 2010-4S, establishing the Ohio Prescription Drug Abuse Task Force (the “Task Force”). The Task Force was created to develop a coordinated and comprehensive approach to Ohio’s prescription ...
Ohio Prescription Drug Abuse Task Force
core   +2 more sources

Sense of control and likelihood of prescription drug misuse 10-years later among middle-aged and older adults. [PDF]

Aging Ment Health, 2023
Miller SE, Hong JH, Almeida DM.
europepmc   +1 more source

Interpretation of Key Updates in the 36th Edition of Clinical and Laboratory Standards Institute M100 Standard

iLABMED, EarlyView.
ABSTRACT The Clinical and Laboratory Standards Institute M100 document serves as a cornerstone standard for clinical microbiology laboratories in China. Maintaining the scientific rigor of its predecessors, the 36th edition incorporates updated epidemiological cutoff values, pharmacokinetic/pharmacodynamic data, and clinical efficacy evidence to revise
Kanghong Xu, Qi Wang, Hui Wang
wiley   +1 more source

High-dose use of pregabalin and gabapentin in France: a retrospective, population-based cohort studyResearch in context

The Lancet Regional Health. Europe
Summary: Background: Following recent developments regarding gabapentinoid (i.e., pregabalin and gabapentin) abuse and misuse in France, this study aims to describe new users of gabapentinoids from 2017 to 2021, estimate the incidence of high-dose use ...
Thomas Soeiro, Marina Uras, Émilie Jouanjus, Maryse Lapeyre-Mestre, Joëlle Micallef   +4 more
doaj   +1 more source

Family history of substance use disorder and likelihood of prescription drug misuse in adults 50 and older. [PDF]

Aging Ment Health, 2023
Schepis TS, Wastila L, McCabe SE.
europepmc   +1 more source

Acute Modafinil Exposure Induces Neurobehavioral Alterations in Zebrafish: Implications for Off‐Label Cognitive Enhancement

Journal of Applied Toxicology, EarlyView.
ABSTRACT Modafinil (2‐(benzhydrylsulfinyl)acetamide) is a psychostimulant commonly prescribed for sleep disorders such as narcolepsy, excessive daytime sleepiness, and obstructive sleep apnea. Recently, its use has extended beyond clinical indications, with neurotypical individuals adopting it as a smart drug to enhance alertness and cognitive ...
Luciane Dellazari da Silva do Prado, Nicole Berton, Nicoli da Rosa Amaral, Inara Carbonera Biazus, Laíse Mattiollo, Jéssica Nardi, Karen Júlia de Souza dos Santos, Natália Freddo, Leonardo José Gil Barcellos, Luciana Grazziotin Rossato‐Grando   +9 more
wiley   +1 more source